Anti-Obesity Effects of Hovenia Dulcis Branches in Mouse Adipocytes, 3t3-l1 Cells, and High-Fat Diet Obese Mice.

IF 1.5 4区 医学 Q4 CHEMISTRY, MEDICINAL Pharmazie Pub Date : 2023-07-01 DOI:10.1691/ph.2023.3518
Min Yeong Choi, Jeong Won Choi, Hyeok Jin Choi, Seung Woo Im, Gwang Hun Park, Jin Boo Jeong
{"title":"Anti-Obesity Effects of <i>Hovenia Dulcis</i> Branches in Mouse Adipocytes, 3t3-l1 Cells, and High-Fat Diet Obese Mice.","authors":"Min Yeong Choi,&nbsp;Jeong Won Choi,&nbsp;Hyeok Jin Choi,&nbsp;Seung Woo Im,&nbsp;Gwang Hun Park,&nbsp;Jin Boo Jeong","doi":"10.1691/ph.2023.3518","DOIUrl":null,"url":null,"abstract":"<p><p><i>Hovenia dulcis</i> has been reported to have various pharmacological activities, but most studies were done with its fruits. However, from an economic point of view, the use of discarded leaves and branches as by-products is very valuable. In this study, the<i>in vitro</i> and<i>in vivo</i> anti-obesity activities of <i>Hovenia dulcis</i> branch extract (HDB) were investigated to evaluate the applicability of HDB as an anti-obesity agent. In differentiated 3T3-L1 cells, HDB inhibited lipid droplet accumulation. And HDB downregulated CEBPα, PPARγ, and perilipin-1, and upregulated ATGL, p-HSL, HSL, p-AMPK, UCP-1, PGC-1α, PRDM16, LC3-II, and p62/SQSTM1. In addition, HDB increased free glycerol content. In HFD-induced obese mice, HDB reduced body weight and total fat weight. In addition, HDB decreased blood LDL-cholesterol, blood total cholesterol, and blood triglyceride. These results indicate that HDB has anti-obesity activity and HDB can be used as a healthy functional food agent for weight reduction.</p>","PeriodicalId":20145,"journal":{"name":"Pharmazie","volume":"78 6","pages":"89-92"},"PeriodicalIF":1.5000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmazie","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1691/ph.2023.3518","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 1

Abstract

Hovenia dulcis has been reported to have various pharmacological activities, but most studies were done with its fruits. However, from an economic point of view, the use of discarded leaves and branches as by-products is very valuable. In this study, thein vitro andin vivo anti-obesity activities of Hovenia dulcis branch extract (HDB) were investigated to evaluate the applicability of HDB as an anti-obesity agent. In differentiated 3T3-L1 cells, HDB inhibited lipid droplet accumulation. And HDB downregulated CEBPα, PPARγ, and perilipin-1, and upregulated ATGL, p-HSL, HSL, p-AMPK, UCP-1, PGC-1α, PRDM16, LC3-II, and p62/SQSTM1. In addition, HDB increased free glycerol content. In HFD-induced obese mice, HDB reduced body weight and total fat weight. In addition, HDB decreased blood LDL-cholesterol, blood total cholesterol, and blood triglyceride. These results indicate that HDB has anti-obesity activity and HDB can be used as a healthy functional food agent for weight reduction.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
牛耳草分支对小鼠脂肪细胞、3t3-l1细胞和高脂饮食肥胖小鼠的抗肥胖作用
据报道,羊角草具有多种药理活性,但大多数研究都是用其果实进行的。然而,从经济的角度来看,利用废弃的树叶和树枝作为副产品是非常有价值的。本研究考察了土茯苓提取物(HDB)的体内和体外抗肥胖活性,以评价其作为抗肥胖药物的适用性。在分化的3T3-L1细胞中,HDB抑制脂滴积聚。HDB下调CEBPα、PPARγ和perilipin-1,上调ATGL、p-HSL、HSL、p-AMPK、UCP-1、PGC-1α、PRDM16、LC3-II和p62/SQSTM1。此外,HDB增加了游离甘油含量。在hfd诱导的肥胖小鼠中,HDB降低了体重和总脂肪重量。此外,HDB降低血液ldl -胆固醇、血液总胆固醇和血液甘油三酯。上述结果表明,HDB具有抗肥胖活性,可作为一种健康的减肥功能性食品剂。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Pharmazie
Pharmazie 医学-化学综合
CiteScore
3.10
自引率
0.00%
发文量
56
审稿时长
1.2 months
期刊介绍: The journal DiePharmazie publishs reviews, experimental studies, letters to the editor, as well as book reviews. The following fields of pharmacy are covered: Pharmaceutical and medicinal chemistry; Pharmaceutical analysis and drug control; Pharmaceutical technolgy; Biopharmacy (biopharmaceutics, pharmacokinetics, biotransformation); Experimental and clinical pharmacology; Pharmaceutical biology (pharmacognosy); Clinical pharmacy; History of pharmacy.
期刊最新文献
Analysis of progression-free and overall survival in ovarian cancer: Bevacizumab treatment outcomes using historical cohort. Comparison of pharmacotherapeutic analgesic response and safety profile of tapentadol with other opioids. Cross-reactivity of triptans and sulfonamide antibiotics - a clinically relevant question? Impact of medication reconciliation and medication reviews on the incidence of preventable adverse drug reactions during hospitalization of elderly patients. A randomized controlled trial. Potential effects of attention deficit hyperactivity disorder medication on body height and body weight in a longitudinal pediatric cohort study, the LIFE Child study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1